Literature DB >> 15655297

Physiology and pathophysiology of proteinase-activated receptors (PARs): PAR-2-mediated proliferation of colon cancer cell.

Masahiro Nishibori1, Shuji Mori, Hideo K Takahashi.   

Abstract

Proteinase-activated receptor-2 (PAR-2) has been demonstrated to be highly expressed in the gastrointestinal tract. In the present minireview, we summarize the effects of PAR-1 and PAR-2 stimulation using their activating peptides and agonist proteinases on the calcium signaling and the cell proliferation in DLD-1 cell, a human colon cancer cell line. PAR-2 but not PAR-1 stimulation induced the enhancement of cell proliferation, whereas both PAR-1 and PAR-2 stimulation induced the transient increase in [Ca(2+)](i). PAR-2 stimulation induced the phosphorylation of MEK1/2 and ERK1/2, but PAR-1 stimulation did not. The inhibition of MEK1/2 by PD98059 completely abolished the proliferative response to PAR-2 stimulation. Thus, MEK-ERK activation plays major role in the PAR-2-mediated proliferative response. The coupling of PARs to calcium signaling and MEK-ERK activation may be independent, and varied dependent on cell types.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655297     DOI: 10.1254/jphs.fmj04005x5

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  11 in total

1.  Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110).

Authors:  J Y Suen; G D Barry; R J Lohman; M A Halili; A J Cotterell; G T Le; D P Fairlie
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Proteinase-activated receptor 2 promotes cancer cell migration through RNA methylation-mediated repression of miR-125b.

Authors:  Lan Yang; Yiming Ma; Wenxiao Han; Weiwei Li; Liang Cui; Xinhua Zhao; Yantao Tian; Zhixiang Zhou; Wengong Wang; Hongying Wang
Journal:  J Biol Chem       Date:  2015-09-09       Impact factor: 5.157

3.  PAR2 Modulators Derived from GB88.

Authors:  Mei-Kwan Yau; Ligong Liu; Jacky Y Suen; Junxian Lim; Rink-Jan Lohman; Yuhong Jiang; Adam J Cotterell; Grant D Barry; Jeffrey Y W Mak; David A Vesey; Robert C Reid; David P Fairlie
Journal:  ACS Med Chem Lett       Date:  2016-10-10       Impact factor: 4.345

4.  Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.

Authors:  Spyridon Christodoulou; Dimitra K Alexopoulou; Christos K Kontos; Andreas Scorilas; Iordanis N Papadopoulos
Journal:  Tumour Biol       Date:  2014-01-16

5.  Proteinase-activated receptor 2 stimulates Na,K-ATPase and sodium reabsorption in native kidney epithelium.

Authors:  Luciana Morla; Gilles Crambert; David Mordasini; Guillaume Favre; Alain Doucet; Martine Imbert-Teboul
Journal:  J Biol Chem       Date:  2008-08-04       Impact factor: 5.157

6.  Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration.

Authors:  S Su; Y Li; Y Luo; Y Sheng; Y Su; R N Padia; Z K Pan; Z Dong; S Huang
Journal:  Oncogene       Date:  2009-06-22       Impact factor: 9.867

7.  Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model.

Authors:  David Pépin; Zhong-Qi Shao; Geneviève Huppé; Andrea Wakefield; Chee-Wui Chu; Zahra Sharif; Barbara C Vanderhyden
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

Review 8.  Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.

Authors:  Marek Z Wojtukiewicz; Dominika Hempel; Ewa Sierko; Stephanie C Tucker; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

9.  Autocrine extra-pancreatic trypsin 3 secretion promotes cell proliferation and survival in esophageal adenocarcinoma.

Authors:  Song Han; Constance W Lee; Jose G Trevino; Steven J Hughes; George A Sarosi
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

Review 10.  New intracellular and molecular aspects in pathophysiology of colorectal cancer.

Authors:  Payman Ziapour; Ramin Ataee; Mohammad Shadifar; Cathy Vaillancourt; Ali Ahmadi; Majid Jafari-Sabet; Amin Ataee
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.